Alison J. Partridge
Brigham and Women's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Alison J. Partridge.
Arthritis & Rheumatism | 1999
Paul R. Fortin; Ann E. Clarke; Lawrence Joseph; Matthew H. Liang; Michael Tanzer; Diane Ferland; Charlotte B. Phillips; Alison J. Partridge; Patrick Bélisle; Anne H. Fossel; Nizar N. Mahomed; Clement B. Sledge; Jeffrey N. Katz
OBJECTIVE To determine whether patients with knee or hip osteoarthritis (OA) who have worse physical function preoperatively achieve a postoperative status that is similar to that of patients with better preoperative function. METHODS This study surveyed an observational cohort of 379 consecutive patients with definite OA who were without other inflammatory joint diseases and were undergoing either total hip or knee replacement in a US (Boston) and a Canadian (Montreal) referral center. Questionnaires on health status (the Short Form 36 and Western Ontario and McMaster Universities Osteoarthritis Index) were administered preoperatively and at 3 and 6 months postoperatively. Physical function and pain due to OA were deemed the most significant outcomes to study. RESULTS Two hundred twenty-two patients returned their questionnaires. Patients in the 2 centers were comparable in age, sex, time to surgery, and proportion of hip/knee surgery. The Boston group had more education, lower comorbidity, and more cemented knee prostheses. Patients undergoing hip or knee replacement in Montreal had lower preoperative physical function and more pain than their Boston counterparts. In patients with lower preoperative physical function, function and pain were not improved postoperatively to the level achieved by those with higher preoperative function. This was most striking in patients undergoing total knee replacement. CONCLUSION Surgery performed later in the natural history of functional decline due to OA of the knee, and possibly of the hip, results in worse postoperative functional status.
The Journal of Allergy and Clinical Immunology | 1999
Nancy A. Shadick; Matthew H. Liang; Alison J. Partridge; Clifton O. Bingham; Elizabeth A. Wright; Anne H. Fossel; Albert L. Sheffer
BACKGROUND Exercise-induced anaphylaxis (EIA) is a unique physical allergy that is triggered by exertion, the clinical spectrum and modifying factors of which have been previously studied. At the time of initial description, it was postulated that other factors contributed to this disorder. OBJECTIVE We sought to determine the clinical course and potential modifying factors in EIA. METHODS In 1993, we conducted a cross-sectional analysis of 671 individuals with exercise-associated symptoms for more than a decade using a validated 75-item questionnaire. Subjects met criteria for EIA if they had anaphylactic symptoms, including hypotension or upper airway obstruction, urticaria, or angioedema with physical exertion but without a passive increase in core body temperature. RESULTS Of 365 (54%) questionnaire respondents, 279 (87%) met criteria for EIA (199 females and 80 males). At the time of study entry, subjects with EIA (mean age, 37.5 years; range, 13 to 77 years) had an average of 10.6 years of symptoms, which were most frequently triggered by aerobic activities such as jogging or brisk walking (78% and 42%, respectively). On average, subjects reported that the frequency of attacks had decreased (47% of subjects) or stabilized (46% of subjects) since onset. One hundred (41%) subjects reported being completely free of attacks in the past year. Subjects reduced their attacks by avoiding exercise during extremely hot or cold weather (44%), avoiding ingestion of certain foods before exercise (37%), and restricting exercise during their allergy season (36%) or humid weather (33%). The most common pharmacologic agents used to manage symptoms were H1 antagonists (56%) and/or epinephrine (31%). However, 28% used no treatment at all. CONCLUSION EIA is an episodic condition in which the frequency of attacks tends to stabilize or decrease over time. Improvement appears to result from individual modification of exercise and avoidance of known environmental and ingestible precipitants.
Lupus | 2003
Elizabeth W. Karlson; Lawren H. Daltroy; C. Rivest; Rosalind Ramsey-Goldman; Elizabeth A. Wright; Alison J. Partridge; Matthew H. Liang; Paul R. Fortin
The goal of this work was to develop an economical way of tracking disease activity for large groups of systemic lupus erythematosus (SLE) patients in clinical studies. A Systemic Lupus Activity Questionnaire (SLAQ) was developed to screen for possible disease activity using items from the Systemic Lupus Activity Measure (SLAM) and tested for its measurement properties. The SLAQ was completed by 93 SLE patients just prior to a scheduled visit. At the visit, a rheumatologist, blinded to SLAQ results, examined the subject and completed a SLAM. Associations among SLAQ, and SLAM (omitting laboratory items) and between individual items from each instrument were assessed with Pearson correlations. Correlations between pairs of instruments were compared using Student’s t-tests. The mean score across all 24 SLAQ items was 11.5 (range 0 -33); mean SLAM without labs was 3.0 (range 0 -13). The SLAQ had a moderately high correlation with SLAM-nolab (r = 0.62, P < 0.0001). Correlations between patient-clinician matched pairs of items ranged from r = 0.06 to 0.71. Positive predictive values for the SLAQ ranged from 56 to 89% for detecting clinically significant disease activity. In studies of SLE, symptoms suggesting disease can be screened by self-report using the SLAQ and then verified by further evaluation.
The American Journal of Medicine | 1995
John S. Sampalis; John M. Esdaile; Thomas A. Medsger; Alison J. Partridge; Carol Yeadon; Jean-Luc Senécal; Daniel Myhal; Manfred Harth; Andrzej Gutkowski; Simon Carette; François Beaudet; John J. Cush; James F. Fries
PURPOSE To assess the long-term prognosis of patients with adult Stills disease for physical and psychological disability, pain, social functioning, social support, medication use, formal education, occupation, time lost from work, and family income, and to contrast these results with those of same-sex sibling controls. PATIENTS AND METHODS Patients were recruited from medical center-based cohorts in Pittsburgh and Eastern Canada and from a national survey of rheumatologists. Patients and same-sex sibling controls completed the Health Assessment Questionnaire for physical disability, the psychological and social function domains of the Arthritis Impact Measurement Scales, and the Interpersonal Skills Evaluation List questionnaire for social support, and replied to questions on medication use, formal education, occupation, time lost from work, and family income. RESULTS One hundred four of 111 eligible adult Stills patients (94%) provided data. They identified 86 same-sex sibling controls, of whom 60 (70%) participated. The mean duration of adult Stills disease was 10 years. Approximately half of patients continued to require medication even 10 years after diagnosis. Patients had significantly higher levels of pain, physical disability, and psychological disability when compared with the controls. However, the levels of pain and physical disability were low compared to patients with other rheumatic diseases. Educational achievement, occupational prestige, social functioning and support, time lost from work, and family income were similar for both patients and controls. CONCLUSIONS Despite causing disability, pain, and, in many, the need for long-term medication, patients with adult Stills disease are resilient. The disease did not interfere with educational attainment, occupational prestige, social functioning and support, time lost from work, or family income.
Arthritis & Rheumatism | 1996
C. Kent Kwoh; Robert W. Simms; Larry G. Anderson; Diane M. Erlandson; Jerry M. Greene; Carolee Moncur; James R. O'Dell; Alison J. Partridge; W. Neal Roberts; Mark L. Robbins; Robert A. Yood; Matthew H. Liang
Arthritis & Rheumatism | 1997
Elizabeth W. Karlson; Lawren H. Daltroy; Robert A. Lew; Elizabeth A. Wright; Alison J. Partridge; Anne H. Fossel; W. Neal Roberts; Steven H. Stern; Karin V. Straaton; Mary C. Wacholtz; Arthur Kavanaugh; Jodi M. Grosflam; Matthew H. Liang
Arthritis & Rheumatism | 1996
Robert W. Simms; C. Kent Kwoh; Larry G. Anderson; Diane M. Erlandson; Jerry M. Greene; Mittie Kelleher; James R. O'Dell; Alison J. Partridge; W. Neal Roberts; Mark L. Robbins; Robert A. Yood; Matthew H. Liang
Arthritis & Rheumatism | 1997
Alison J. Partridge; Anne H. Fossel; Elizabeth W. Karlson; Robert A. Lew; Elizabeth A. Wright; Lawren H. Daltroy; Matthew H. Liang; Karin V. Straaton; Steven H. Stern; Arthur Kavanaugh; W. Neal Roberts
Arthritis & Rheumatism | 1995
Elizabeth W. Karlson; Lawren H. Daltroy; Robert A. Lew; Elizabeth A. Wright; Alison J. Partridge; W. Neal Roberts; Steven H. Stern; Karin V. Straaton; Mary C. Wacholtz; Jodi M. Grosflam; Matthew H. Liang
Journal of Pediatric Psychology | 1992
Lawren H. Daltroy; Martin G. Larson; Hoiley M. Eaton; Alison J. Partridge; I. Barry Pless; Malcolm P. Rogers; Matthew H. Liang